Michael M Bergmann

23PUBLICATIONS
119CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markersIsotope geochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 08, 2025
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial.

Rebecca Zirnbauer, Simon Hametner, Jutta Bergler-Klein

|Nov 05, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures.

Julijan Kabiljo, Anna Theophil, Jakob Homola

|Aug 13, 2024
Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer.

Victoria Stary, Ram V Pandey, Julia List

|Mar 22, 2024
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality.

Marie-Christine Albert, Iratxe Uranga-Murillo, Maykel Arias

|Feb 28, 2023
Evaluation of Intestinal Fibrosis with <sup>68</sup>Ga-FAPI PET/MR Enterography in Crohn Disease.

Martina Scharitzer, Andrea Macher-Beer, Thomas Mang

|Jan 21, 2023
Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition.

Velina S Atanasova, Angelika Riedl, Marcus Strobl

Pageof 4

Frequent Collaborators

6 joint publications

Johannes Laengle

4 joint publications

Andrea Macher-Beer

3 joint publications

Lukas W Unger

3 joint publications

Anton Stift